An


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
02 2020
Historique:
received: 08 04 2019
accepted: 06 07 2019
pubmed: 22 7 2019
medline: 25 7 2020
entrez: 21 7 2019
Statut: ppublish

Résumé

In preclinical trials, the recently developed tracer 2-methoxy-

Identifiants

pubmed: 31324713
pii: jnumed.119.229542
doi: 10.2967/jnumed.119.229542
doi:

Substances chimiques

Antigens, Surface 0
Fluorine Radioisotopes 0
Gallium Radioisotopes 0
Ligands 0
Gallium-68 98B30EPP5S
FOLH1 protein, human EC 3.4.17.21
Glutamate Carboxypeptidase II EC 3.4.17.21
Fluorine-18 GZ5I74KB8G

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

202-209

Informations de copyright

© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Felix Dietlein (F)

Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany markus.dietlein@uk-koeln.de.
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Melanie Hohberg (M)

Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.

Carsten Kobe (C)

Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.

Boris D Zlatopolskiy (BD)

Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital of Cologne, Cologne, Germany.

Philipp Krapf (P)

INM-5: Nuclear Chemistry, Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Jülich, Germany; and.

Heike Endepols (H)

Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.
Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital of Cologne, Cologne, Germany.

Philipp Täger (P)

Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.

Jochen Hammes (J)

Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.

Axel Heidenreich (A)

Department of Urology, University Hospital of Cologne, Cologne, Germany.

Bernd Neumaier (B)

Institute of Radiochemistry and Experimental Molecular Imaging, University Hospital of Cologne, Cologne, Germany.
INM-5: Nuclear Chemistry, Institute of Neuroscience and Medicine, Forschungszentrum Jülich, Jülich, Germany; and.

Alexander Drzezga (A)

Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany.

Markus Dietlein (M)

Department of Nuclear Medicine, University Hospital of Cologne, Cologne, Germany markus.dietlein@uk-koeln.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH